↓ Skip to main content

Oxidative Stress and Neurodegenerative Diseases: A Review of Upstream and Downstream Antioxidant Therapeutic Options

Overview of attention for article published in Current Neuropharmacology, March 2009
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#4 of 473)
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

news
5 news outlets
blogs
2 blogs
twitter
22 tweeters
patent
5 patents
facebook
6 Facebook pages
googleplus
2 Google+ users
video
4 video uploaders

Citations

dimensions_citation
1360 Dimensions

Readers on

mendeley
1253 Mendeley
citeulike
2 CiteULike
connotea
1 Connotea
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Oxidative Stress and Neurodegenerative Diseases: A Review of Upstream and Downstream Antioxidant Therapeutic Options
Published in
Current Neuropharmacology, March 2009
DOI 10.2174/157015909787602823
Pubmed ID
Authors

Bayani Uttara, Ajay V. Singh, Paolo Zamboni, R.T Mahajan, Ajay Singh, R. Mahajan

Abstract

Free radicals are common outcome of normal aerobic cellular metabolism. In-built antioxidant system of body plays its decisive role in prevention of any loss due to free radicals. However, imbalanced defense mechanism of antioxidants, overproduction or incorporation of free radicals from environment to living system leads to serious penalty leading to neuro-degeneration. Neural cells suffer functional or sensory loss in neurodegenerative diseases. Apart from several other environmental or genetic factors, oxidative stress (OS) leading to free radical attack on neural cells contributes calamitous role to neuro-degeneration. Though, oxygen is imperative for life, imbalanced metabolism and excess reactive oxygen species (ROS) generation end into a range of disorders such as Alzheimer's disease, Parkinson's disease, aging and many other neural disorders. Toxicity of free radicals contributes to proteins and DNA injury, inflammation, tissue damage and subsequent cellular apoptosis. Antioxidants are now being looked upon as persuasive therapeutic against solemn neuronal loss, as they have capability to combat by neutralizing free radicals. Diet is major source of antioxidants, as well as medicinal herbs are catching attention to be commercial source of antioxidants at present. Recognition of upstream and downstream antioxidant therapy to oxidative stress has been proved an effective tool in alteration of any neuronal damage as well as free radical scavenging. Antioxidants have a wide scope to sequester metal ions involved in neuronal plaque formation to prevent oxidative stress. In addition, antioxidant therapy is vital in scavenging free radicals and ROS preventing neuronal degeneration in post-oxidative stress scenario.

Twitter Demographics

The data shown below were collected from the profiles of 22 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 1,253 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 7 <1%
United States 4 <1%
India 4 <1%
Spain 4 <1%
South Africa 2 <1%
Mexico 2 <1%
Portugal 2 <1%
Brazil 2 <1%
Ireland 2 <1%
Other 17 1%
Unknown 1207 96%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 294 23%
Student > Bachelor 257 21%
Student > Master 228 18%
Researcher 114 9%
Unspecified 105 8%
Other 255 20%
Readers by discipline Count As %
Agricultural and Biological Sciences 376 30%
Unspecified 163 13%
Biochemistry, Genetics and Molecular Biology 152 12%
Medicine and Dentistry 150 12%
Chemistry 112 9%
Other 300 24%

Attention Score in Context

This research output has an Altmetric Attention Score of 87. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 April 2019.
All research outputs
#174,765
of 12,988,515 outputs
Outputs from Current Neuropharmacology
#4
of 473 outputs
Outputs of similar age
#1,831
of 146,266 outputs
Outputs of similar age from Current Neuropharmacology
#1
of 10 outputs
Altmetric has tracked 12,988,515 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 473 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.4. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 146,266 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 10 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them